Wird geladen...

Stopping screening, when and how?

Screening for prostate cancer (PC) is still controversial despite randomized trials has found that PC mortality is decreased. The major concern is the high rate of over-diagnosis and subsequent harms that may follow in many men who never would have had any symptoms during life-time if not screened....

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Transl Androl Urol
1. Verfasser: Hugosson, Jonas
Format: Artigo
Sprache:Inglês
Veröffentlicht: AME Publishing Company 2018
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5861277/
https://ncbi.nlm.nih.gov/pubmed/29594019
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tau.2017.12.39
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!